Literature DB >> 31482466

Optimized Expression of Duck Tembusu Virus E Gene Delivered by a Vectored Duck Enteritis Virus In Vitro.

Liu Chen1, Bin Yu1, Jonggang Hua1, Zheng Ni1, Weicheng Ye1, Tao Yun1, Cun Zhang2.   

Abstract

In our previous study, a recombinant duck enteritis virus (DEV) delivering codon-optimized E gene (named as E-ch) of duck Tembusu virus (DTMUV) optimized referring to chicken's codon bias has been obtained based on the infectious bacterial artificial chromosome (BAC) clone of duck enteritis virus vaccine strain pDEV-EF1, but the expression level of E-ch in recombinant virus rDEV-E-ch-infected cells was very low. To optimize DTMUV E gene expression delivered by the vectored DEV, different forms of E gene (collectively called EG) including origin E gene (E-ori), truncated E451-ori gene, codon-optimized E-dk gene optimized referring to duck's codon bias, as well as the truncated E451-ch and E451-dk, Etpa-ori and Etpa-451-ori, which contain prefixing chick TPA signal peptide genes, were cloned into transfer vector pEP-BGH-end, and several recombinant plasmids pEP-BGH-EG were constructed. Then the expression cassettes pCMV-EG-polyABGH amplified from pEP-BGH-EG by PCR were inserted into US7/US8 gene intergenic region of pDEV-EF1 by two-step Red/ET recombination, 7 strain recombinant mutated BAC clones pDEV-EG carrying different E genes were constructed. Next, the recombinant viruses rDEV-EG were reconstituted from chicken embryo fibroblasts (CEFs) by calcium phosphate precipitation. Western blot analysis showed that E or E451 protein is expressed in rDEV-E-ori, rDEV-E-ch, rDEV-Etpa-ori, rDEV-E451-ori, rDEV-E451-dk, and rDEV-E451-ch-infected CEFs, and protein expression level in rDEV-E451-dk-infected CEFs is the highest. These studies have laid a foundation for developing bivalent vaccine controlling DEV and DTMUV infection.

Entities:  

Keywords:  Duck Tembusu virus; Duck enteritis virus; E antigen; Optimized expression; Vectored vaccine

Mesh:

Substances:

Year:  2019        PMID: 31482466     DOI: 10.1007/s12033-019-00206-1

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  29 in total

1.  Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

Authors:  David W C Beasley; Alan D T Barrett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.

Authors:  B Karsten Tischer; Jens von Einem; Benedikt Kaufer; Nikolaus Osterrieder
Journal:  Biotechniques       Date:  2006-02       Impact factor: 1.993

3.  Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Kyung Min Chung; Grant E Nybakken; Bruce S Thompson; Michael J Engle; Anantha Marri; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Immune response to synthetic peptides of dengue prM protein.

Authors:  Susana Vázquez; María Guadalupe Guzmán; Gerardo Guillen; Glay Chinea; Ana Beatriz Pérez; Maritza Pupo; Rosmary Rodriguez; Osvaldo Reyes; Hilda Elisa Garay; Iselys Delgado; Gissel García; Mayling Alvarez
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

5.  Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.

Authors:  Michael M Lieberman; David E Clements; Steven Ogata; Gordon Wang; Gloria Corpuz; Teri Wong; Tim Martyak; Lynne Gilson; Beth-Ann Coller; Julia Leung; Douglas M Watts; Robert B Tesh; Marina Siirin; Amelia Travassos da Rosa; Tom Humphreys; Carolyn Weeks-Levy
Journal:  Vaccine       Date:  2006-08-30       Impact factor: 3.641

6.  Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.

Authors:  Tomohiro Ishikawa; Gongbo Wang; Douglas G Widman; Ernesto Infante; Evandro R Winkelmann; Nigel Bourne; Peter W Mason
Journal:  Vaccine       Date:  2011-07-26       Impact factor: 3.641

7.  Generation of an infectious clone of duck enteritis virus (DEV) and of a vectored DEV expressing hemagglutinin of H5N1 avian influenza virus.

Authors:  Jichun Wang; Nikolaus Osterrieder
Journal:  Virus Res       Date:  2011-04-28       Impact factor: 3.303

8.  Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.

Authors:  Cheng-Wen Lin; Kuang-Ting Liu; Hong-Da Huang; Wei-June Chen
Journal:  Biotechnol Lett       Date:  2007-09-18       Impact factor: 2.461

9.  Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.

Authors:  Venkatramana D Krishna; Manjuladevi Rangappa; Vijaya Satchidanandam
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

10.  Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells.

Authors:  Kyung Min Chung; Bruce S Thompson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

View more
  1 in total

1.  The difference in CD4+ T cell immunity between high- and low-virulence Tembusu viruses is mainly related to residues 151 and 304 in the envelope protein.

Authors:  Runze Meng; Baolin Yang; Chonglun Feng; Jingjing Huang; Xiaoyan Wang; Dabing Zhang
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.